Secondary Prevention With Paroxetine vs. Placebo in Subthreshold Posttraumatic Stress Disorder (PTSD).
Phase of Trial: Phase IV
Latest Information Update: 05 Feb 2018
At a glance
- Drugs Paroxetine (Primary)
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- 11 Aug 2008 Actual end date added (July 2008) as reported by ClinicalTrials.gov.
- 11 Aug 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Nov 2007 New trial record.